Centessa Pharmaceuticals (CNTA) Times Interest Earned (2022 - 2025)
Historic Times Interest Earned for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to -$18.61.
- Centessa Pharmaceuticals' Times Interest Earned fell 255.8% to -$18.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.21, marking a year-over-year decrease of 2098.16%. This contributed to the annual value of -$19.93 for FY2024, which is 1524.12% down from last year.
- Per Centessa Pharmaceuticals' latest filing, its Times Interest Earned stood at -$18.61 for Q3 2025, which was down 255.8% from -$18.95 recorded in Q2 2025.
- Over the past 5 years, Centessa Pharmaceuticals' Times Interest Earned peaked at -$10.7 during Q1 2025, and registered a low of -$41.39 during Q2 2022.
- Moreover, its 4-year median value for Times Interest Earned was -$18.88 (2022), whereas its average is -$21.27.
- Its Times Interest Earned has fluctuated over the past 5 years, first soared by 5363.02% in 2023, then crashed by 11979.0% in 2024.
- Centessa Pharmaceuticals' Times Interest Earned (Quarter) stood at -$18.88 in 2022, then grew by 27.52% to -$13.69 in 2023, then plummeted by 119.79% to -$30.08 in 2024, then skyrocketed by 38.13% to -$18.61 in 2025.
- Its last three reported values are -$18.61 in Q3 2025, -$18.95 for Q2 2025, and -$10.7 during Q1 2025.